51 related articles for article (PubMed ID: 32340482)
1. Temporal Trends and Practice Patterns for Inpatient Management of Malignant Extrinsic Ureteral Obstruction in the United States.
Haas CR; Shah O; Hyams ES
J Endourol; 2020 Aug; 34(8):828-835. PubMed ID: 32340482
[No Abstract] [Full Text] [Related]
2. Longitudinal Outcomes of Malignant Ureteral Obstruction Secondary to Ovarian Cancer: Predictors of Resolution and the Role of Surgical Management.
Faidley KN; Botkin HE; Loeffler BT; Mott SL; Hansen SC; Hill EK; Erickson BA
Urology; 2024 Apr; 186():101-106. PubMed ID: 38350551
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous nephrostomy versus retrograde ureteral stenting for acute upper obstructive uropathy: a systematic review and meta-analysis.
Zul Khairul Azwadi I; Norhayati MN; Abdullah MS
Sci Rep; 2021 Mar; 11(1):6613. PubMed ID: 33758312
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of perioperative outcomes and safety of percutaneous nephrostomy
Wang X; Wu G; Wang T; Liu S; Ding G; Mao Q; Chu Y; Cui Y; Wu J
Ther Adv Urol; 2024; 16():17562872241241854. PubMed ID: 38618182
[TBL] [Abstract][Full Text] [Related]
5. Management of malignant ureteric obstruction with ureteric stenting or percutaneous nephrostomy.
Blackmur J;
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38406883
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous nephrostomy versus ureteral stent in hydronephrosis secondary to obstructive urolithiasis: A systematic review and meta-analysis.
Cardoso A; Coutinho A; Neto G; Anacleto S; Tinoco CL; Morais N; Cerqueira-Alves M; Lima E; Mota P
Asian J Urol; 2024 Apr; 11(2):261-270. PubMed ID: 38680594
[TBL] [Abstract][Full Text] [Related]
7. Stents for malignant ureteral obstruction.
Pavlovic K; Lange D; Chew BH
Asian J Urol; 2016 Jul; 3(3):142-149. PubMed ID: 29264182
[TBL] [Abstract][Full Text] [Related]
8. Retrograde ureteral catheterization under local anesthesia for emergency drainage in patients with infection and hydronephrosis secondary to ureteral calculi: Experience from a tertiary care hospital.
Hsu CK; Young WL; Wu SY
Tzu Chi Med J; 2023; 35(4):317-321. PubMed ID: 38035064
[TBL] [Abstract][Full Text] [Related]
9. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
Dhani FK; Daryanto B; Seputra KP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
[TBL] [Abstract][Full Text] [Related]
10. The challenging management of malignant ureteral obstruction: Analysis of a series of 188 cases.
Artiles Medina A; Laso García I; González Tello F; Álvarez Rodríguez S; Hevia Palacios M; Mata Alcaraz M; Mínguez Ojeda C; Arias Funez F; Gómez Dos Santos V; Burgos Revilla FJ
Curr Urol; 2024 Mar; 18(1):34-42. PubMed ID: 38505156
[TBL] [Abstract][Full Text] [Related]
11. National consensus survey on management approaches for upper urinary tract obstruction: A comparative analysis of retrograde ureteric stent and percutaneous nephrostomy.
Quaresma V; Magalhães F; Marconi L; Lima J; Lopes M; Ferreira AM; Nunes P; Figueiredo A
Arch Ital Urol Androl; 2023 Dec; 95(4):12118. PubMed ID: 38193221
[TBL] [Abstract][Full Text] [Related]
12. The Management of Symptomatic Hydronephrosis in Pregnancy.
Hosny M; Chan K; Ibrahim M; Sharma V; Vasdev N
Cureus; 2024 Jan; 16(1):e52146. PubMed ID: 38222991
[TBL] [Abstract][Full Text] [Related]
13. Malignant peritoneal mesothelioma presenting with bilateral hydronephrosis and renal insufficiency: a case report and literature review.
Luo J; Pan J; Zhong C; Wang L; Zhang H
Front Surg; 2024; 11():1342657. PubMed ID: 38721020
[TBL] [Abstract][Full Text] [Related]
14. Nephrostomy tube versus double J ureteral stent in patients with malignant ureteric obstruction. A systematic review and meta-analysis of comparative studies.
Gauhar V; Pirola GM; Scarcella S; De Angelis MV; Giulioni C; Rubilotta E; Gubbiotti M; Lim EJ; Law YXT; Wroclawski ML; Tiong HY; Castellani D
Int Braz J Urol; 2022; 48(6):903-914. PubMed ID: 36037256
[TBL] [Abstract][Full Text] [Related]
15. The Current Status of Palliative Care, Hospice, and End-of-Life Health Care Utilization in Patients With Malignant Ureteral Obstruction.
Felice MD; Koehne EL; Patel HD; Elliott N; Hekman L; Lewer O; Rahman F; Petix S; Ellis J; Delos Santos G
Urol Pract; 2024 Jan; 11(1):187-196. PubMed ID: 38117967
[TBL] [Abstract][Full Text] [Related]
16. Serum creatinine trajectory after drainage of kidneys with bilateral malignant ureteral obstruction: a prospective non-randomized comparative study.
Gadelkareem RA; Abdelraouf AM; El-Taher AM; Ahmed AI; Shalaby MM
BMC Urol; 2023 Feb; 23(1):24. PubMed ID: 36814273
[TBL] [Abstract][Full Text] [Related]
17. Acute kidney injury due to bilateral malignant ureteral obstruction: Is there an optimal mode of drainage?
Gadelkareem RA; Abdelraouf AM; El-Taher AM; Ahmed AI
World J Nephrol; 2022 Nov; 11(6):146-163. PubMed ID: 36530794
[TBL] [Abstract][Full Text] [Related]
18. Predictors of nadir serum creatinine after drainage of bilaterally obstructed kidneys due to different etiologies.
Gadelkareem RA; Abdelraouf AM; El-Taher AM; Ahmed AI; Mohammed N
Int Urol Nephrol; 2022 Sep; 54(9):2105-2116. PubMed ID: 35794400
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of in vitro urine flow in single and tandem stented ureters subject to extrinsic ureteral obstruction.
Dror I; Harris T; Kalchenko V; Shilo Y; Berkowitz B
Int J Urol; 2022 Oct; 29(10):1221-1226. PubMed ID: 35649584
[TBL] [Abstract][Full Text] [Related]
20. Treatment efficacy and prognosis analysis in locally advanced or metastatic colorectal cancer patients with hydronephrosis.
Tong G; Chen B; Zhang M; Wang T; Wu X; Yan Y; Wang S; Li S
Mol Clin Oncol; 2022 Jun; 16(6):106. PubMed ID: 35620214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
